AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
DEL PRIS
SecurityDE:4AB / AbbVie Inc.
InstitutionHamel Associates, Inc.
Latest Disclosed Ownership21,140 shares
Latest Disclosed Value $ 4,597,739
Hamel Associates, Inc. reports 2.85% increase in ownership of 4AB / AbbVie Inc.

On May 7, 2026 - Hamel Associates, Inc. filed a 13F-HR form disclosing ownership of 21,140 shares of AbbVie Inc. (DE:4AB) valued at $3,919,356 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 20,555 shares of AbbVie Inc.. This represents a change in shares of 2.85% during the quarter. The current value of the position is $3,984,890 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ABBVIE COM 00287Y109 21,140 585 2.85 4,598 -2.11 1.3117
2026-02-11 2025-12-31 13F ABBVIE COM 00287Y109 20,555 0 0.00 4,697 -1.32 1.4157
2026-02-11 2025-12-31 13F ABBVIE COM 00287Y109 20,555 4,697
2026-02-11 2025-12-31 13F ABBVIE COM 00287Y109 20,555 4,697
2026-02-11 2025-12-31 13F ABBVIE COM 00287Y109 20,555 4,697
2026-02-11 2025-12-31 13F ABBVIE COM 00287Y109 20,555 4,697
2026-02-11 2025-12-31 13F ABBVIE COM 00287Y109 20,555 4,697
2025-11-12 2025-09-30 13F ABBVIE COM 00287Y109 20,555 0 0.00 4,759 24.74 1.4635
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 20,555 -150 -0.72 3,815 -12.06 1.2922
2025-05-06 2025-03-31 13F ABBVIE COM 00287Y109 20,705 150 0.73 4,338 18.78 1.4744
2025-02-05 2024-12-31 13F ABBVIE COM 00287Y109 20,555 0 0.00 3,653 -10.03 1.1756
2024-11-05 2024-09-30 13F ABBVIE COM 00287Y109 20,555 0 0.00 4,059 15.15 1.2403
2024-08-02 2024-06-30 13F ABBVIE COM 00287Y109 20,555 -3,666 -15.14 3,526 -20.07 1.1110
2024-04-23 2024-03-31 13F ABBVIE COM 00287Y109 24,221 -2,975 -10.94 4,411 4.65 1.4145
2024-02-08 2023-12-31 13F ABBVIE COM 00287Y109 27,196 -225 -0.82 4,215 3.11 1.4851
2023-11-03 2023-09-30 13F ABBVIE COM 00287Y109 27,421 0 0.00 4,087 10.64 1.4928
2023-08-08 2023-06-30 13F ABBVIE COM 00287Y109 27,421 -225 -0.81 3,694 -16.14 1.2928
2023-05-08 2023-03-31 13F ABBVIE COM 00287Y109 27,646 -65 -0.23 4,406 -1.63 1.5264
2023-02-06 2022-12-31 13F ABBVIE COM 00287Y109 27,711 -250 -0.89 4,478 19.32 1.5579
2022-11-09 2022-09-30 13F ABBVIE COM 00287Y109 27,961 -300 -1.06 3,753 -13.29 1.4850
2022-08-08 2022-06-30 13F ABBVIE COM 00287Y109 28,261 -250 -0.88 4,328 -6.36 1.7066
2022-05-06 2022-03-31 13F ABBVIE COM 00287Y109 28,511 -4 -0.01 4,622 19.71 1.6433
2022-02-08 2021-12-31 13F ABBVIE COM 00287Y109 28,515 50 0.18 3,861 25.72 1.3848
2021-11-08 2021-09-30 13F ABBVIE COM 00287Y109 28,465 1,310 4.82 3,071 0.39 1.1985
2021-08-04 2021-06-30 13F ABBVIE COM 00287Y109 27,155 13,250 95.29 3,059 103.26 1.1665
2021-05-04 2021-03-31 13F ABBVIE COM 00287Y109 13,905 13,905 1,505 0.5803
2018-05-03 2018-03-31 13F ABBVIE COM 00287Y109 0 -2,150 -100.00 0 -100.00
2018-02-13 2017-12-31 13F ABBVIE COM 00287Y109 2,150 2,150 208 0.0983
2017-05-09 2017-03-31 13F ABBVIE COM 00287Y109 0 -10,075 -100.00 0 -100.00
2017-02-14 2016-12-31 13F ABBVIE COM 00287Y109 10,075 -1,475 -12.77 631 -13.32 0.3250
2016-11-10 2016-09-30 13F ABBVIE COM 00287Y109 11,550 -10,000 -46.40 728 -45.43 0.3850
2016-08-08 2016-06-30 13F ABBVIE COM 00287Y109 21,550 -1,200 -5.27 1,334 2.69 0.6911
2016-05-02 2016-03-31 13F ABBVIE COM 00287Y109 22,750 -250 -1.09 1,299 -4.63 0.6891
2016-02-16 2015-12-31 13F ABBVIE COM 00287Y109 23,000 -450 -1.92 1,362 6.74 0.8690
2015-11-17 2015-09-30 13F ABBVIE COM 00287Y109 23,450 0 0.00 1,276 -19.04 0.9072
2015-08-17 2015-06-30 13F ABBVIE COM 00287Y109 23,450 1,025 4.57 1,576 20.12 1.0362
2015-05-14 2015-03-31 13F ABBVIE COM 00287Y109 22,425 1,300 6.15 1,312 -5.07 0.8662
2015-02-17 2014-12-31 13F ABBVIE COM 00287Y109 21,125 0 0.00 1,382 13.28 0.8978
2014-11-21 2014-09-30 13F/A-1 ABBVIE COM 00287Y109 21,125 -2,225 -9.53 1,220 -7.65 0.8133
2014-11-12 2014-09-30 13F ABBVIE COM 00287Y109 21,125 1,220
2014-08-15 2014-06-30 13F ABBVIE COM 00287Y109 23,350 -100 -0.43 1,321 9.63 0.8718
2014-05-13 2014-03-31 13F ABBVIE COM 00287Y109 23,450 -5,225 -18.22 1,205 -20.41 0.8343
2014-02-18 2013-12-31 13F ABBVIE COM 00287Y109 28,675 28,675 1,514 1.0617
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.